Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than
females and is attributed to historical differences in exposures with world-standardised …

The treatment paradigm for malignant pleural mesothelioma (MPM) has changed little in the
last 18 years. Radical intent treatment, consisting of surgical resection, radiotherapy and …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Intraoperative fluorescence imaging (IFI) can improve real‐time identification of cancer cells
during an operation. Phase I clinical trials in thoracic surgery have demonstrated that IFI with …

Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Background Near-infrared (NIR) imaging using the second time window of indocyanine
green (ICG) allows localization of pulmonary, pleural, and mediastinal malignancies during …

Importance Outcomes of localized malignant pleural mesothelioma (MPM) remain poor
despite multimodality therapy. It is unclear what role disparities have in the overall survival …

There is a strong rationale for inhibiting angiogenesis in mesothelioma. Vascular endothelial
growth factor (VEGF) is an autocrine growth factor in mesothelioma and a potent mitogen for …

Objectives Malignant mesothelioma is an uncommon cancer associated with asbestos
exposure, predominantly occupational. Asbestos has been banned in Australia since 2003 …

Objectives Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer with a
poor prognosis and limited treatment options. This study assessed the characteristics …